SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-018477
Filing Date
2023-05-08
Accepted
2023-05-08 08:06:20
Documents
54
Period of Report
2023-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prld-20230508.htm   iXBRL 8-K 69218
2 EX-99.1 prld-ex99_1.htm EX-99 222305
3 EX-99.2 prld-ex99_2.htm EX-99 33151
4 GRAPHIC img268059179_0.jpg GRAPHIC 9445
5 GRAPHIC prld-ex99_2s1.jpg GRAPHIC 380980
6 GRAPHIC prld-ex99_2s2.jpg GRAPHIC 624567
7 GRAPHIC prld-ex99_2s3.jpg GRAPHIC 315715
8 GRAPHIC prld-ex99_2s4.jpg GRAPHIC 318049
9 GRAPHIC prld-ex99_2s5.jpg GRAPHIC 323077
10 GRAPHIC prld-ex99_2s6.jpg GRAPHIC 354488
11 GRAPHIC prld-ex99_2s7.jpg GRAPHIC 323443
12 GRAPHIC prld-ex99_2s8.jpg GRAPHIC 317741
13 GRAPHIC prld-ex99_2s9.jpg GRAPHIC 315397
14 GRAPHIC prld-ex99_2s10.jpg GRAPHIC 412433
15 GRAPHIC prld-ex99_2s11.jpg GRAPHIC 467833
16 GRAPHIC prld-ex99_2s12.jpg GRAPHIC 398744
17 GRAPHIC prld-ex99_2s13.jpg GRAPHIC 340396
18 GRAPHIC prld-ex99_2s14.jpg GRAPHIC 379362
19 GRAPHIC prld-ex99_2s15.jpg GRAPHIC 315892
20 GRAPHIC prld-ex99_2s16.jpg GRAPHIC 310306
21 GRAPHIC prld-ex99_2s17.jpg GRAPHIC 349563
22 GRAPHIC prld-ex99_2s18.jpg GRAPHIC 325709
23 GRAPHIC prld-ex99_2s19.jpg GRAPHIC 397428
24 GRAPHIC prld-ex99_2s20.jpg GRAPHIC 267654
25 GRAPHIC prld-ex99_2s21.jpg GRAPHIC 341655
26 GRAPHIC prld-ex99_2s22.jpg GRAPHIC 305701
27 GRAPHIC prld-ex99_2s23.jpg GRAPHIC 326233
28 GRAPHIC prld-ex99_2s24.jpg GRAPHIC 386186
29 GRAPHIC prld-ex99_2s25.jpg GRAPHIC 396471
30 GRAPHIC prld-ex99_2s26.jpg GRAPHIC 333007
31 GRAPHIC prld-ex99_2s27.jpg GRAPHIC 315041
32 GRAPHIC prld-ex99_2s28.jpg GRAPHIC 308674
33 GRAPHIC prld-ex99_2s29.jpg GRAPHIC 419256
34 GRAPHIC prld-ex99_2s30.jpg GRAPHIC 320261
35 GRAPHIC prld-ex99_2s31.jpg GRAPHIC 410292
36 GRAPHIC prld-ex99_2s32.jpg GRAPHIC 357015
37 GRAPHIC prld-ex99_2s33.jpg GRAPHIC 393963
38 GRAPHIC prld-ex99_2s34.jpg GRAPHIC 334537
39 GRAPHIC prld-ex99_2s35.jpg GRAPHIC 355704
40 GRAPHIC prld-ex99_2s36.jpg GRAPHIC 336764
41 GRAPHIC prld-ex99_2s37.jpg GRAPHIC 400986
42 GRAPHIC prld-ex99_2s38.jpg GRAPHIC 339285
43 GRAPHIC prld-ex99_2s39.jpg GRAPHIC 386984
  Complete submission text file 0000950170-23-018477.txt   19775980

Data Files

Seq Description Document Type Size
44 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prld-20230508_lab.xml EX-101.LAB 17736
45 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prld-20230508.xsd EX-101.SCH 2465
46 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prld-20230508_pre.xml EX-101.PRE 11109
48 EXTRACTED XBRL INSTANCE DOCUMENT prld-20230508_htm.xml XML 4717
Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39527 | Film No.: 23895918
SIC: 2834 Pharmaceutical Preparations